Search
Viridian Therapeutics Inc
VRDNAdd to Watchlist
17.320USD
+0.040+0.23%
Close 06/24, 16:00（ET）Quotes delayed by 15 min
1.91BMarket Cap
LossP/E TTM
Viridian Therapeutics Inc's Company Valuation
Currency: USD Updated: 2026-06-24The current valuation score of Viridian Therapeutics Inc is 6.86, ranking 284 out of 388 in the Biotechnology & Medical Research industry. Its current P/E ratio is -4.33, which is -50.06% below the recent high of -2.16 and -114.42% above the recent low of -9.29.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.
